These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3518241)

  • 1. [Use of prodigiozan in the combined therapy of infectious diseases (a review of the literature)].
    Frolov VM; Rychnev VE
    Vrach Delo; 1986 Feb; (2):111-4. PubMed ID: 3518241
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of prodigiozan in the overall treatment of pulmonary tuberculosis in children and adolescents].
    Kshanovskiĭ SA; Rushchak VA; Tsymbaliuk GF; Kostromina VP; Medvedeva MM
    Probl Tuberk; 1980 Jan; (1):33-6. PubMed ID: 6966060
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunomodulating therapy in protracted pneumonias].
    Sil'vestrov VP; Karaulov AV; Likov VF
    Sov Med; 1983; (7):14-8. PubMed ID: 6623174
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of prodigiozan and zymosan in treating children with viral hepatitis A].
    Lebenzon SS; Maianskiĭ DN; Gavrilova NI; Kutina SN
    Pediatriia; 1988; (6):27-30. PubMed ID: 3186403
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibility of increasing the efficacy of antibiotic therapy of erysipelas using combinations of methyluracil with prodigiozan].
    Frolov VM; Rychnev VE
    Antibiot Med Biotekhnol; 1985 May; 30(5):375-8. PubMed ID: 4026258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of prodigiozan and pyrimidine derivatives on the effectiveness of the antibiotic therapy of experimental infections].
    Bakirov AB
    Antibiotiki; 1979 Sep; 24(9):673-8. PubMed ID: 384893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
    Vereshchagin IA; Zhuravleva OD
    Antibiotiki; 1984 Oct; 29(10):791-4. PubMed ID: 6439109
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative assessment of pathogenic agents in the combined treatment of respiratory organ tuberculosis].
    Karapetian ET; Markova EF; Gasparian AA; Apresian EA; Saakian AL
    Probl Tuberk; 1982 Mar; (3):40-4. PubMed ID: 7088922
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the effectiveness of prodigiozan in acute respiratory viral infections in young infants].
    Raĭnite-Audinene AB; Uspenskiĭ IuS; Priĭmiagi LS; Kremerman IB; Voloshina LZ
    Pediatriia; 1979 Dec; (12):44-6. PubMed ID: 523271
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of comprehensive antibacterial therapy in combination with prodigiozan on energy metabolic indices in children and adolescents with pulmonary tuberculosis].
    Kshanovs'kyĭ SA; Rushchak VA; Maliuk VI; Vel'tman RV; Polner RA
    Pediatr Akus Ginekol; 1979; (3):16-8. PubMed ID: 379787
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prodigiozan in the therapy of destructive pulmonary tuberculosis].
    Kornilova ZKh; Svitneva AS
    Probl Tuberk; 1980 Jan; (1):30-2. PubMed ID: 7367422
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prodigiozan aerosols in the treatment of nonspecific respiratory organ diseases in children].
    Pedanova VM; Smorchkov AP; Furer NM; Iurina TM; Savitskaia KL
    Antibiotiki; 1979 Aug; 24(8):632-5. PubMed ID: 485115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of prodigiozan-provoked exacerbation or chronic salpingo-oophoritis].
    Strugatskiĭ VM; Rastorgueva VM; Tsoĭ S
    Akush Ginekol (Mosk); 1987 Nov; (11):35-7. PubMed ID: 3439565
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of thymalin and prodigiozan in the complex treatment of patients with dysentery].
    Boĭko IN; Khavinson VKh; Morozov VG
    Voen Med Zh; 1985 Jul; (7):45-6. PubMed ID: 3901509
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of prodigiozan and lysozyme in ENT organ diseases].
    Brofman AV
    Zh Ushn Nos Gorl Bolezn; 1980; 1():46-51. PubMed ID: 7361524
    [No Abstract]   [Full Text] [Related]  

  • 16. [Differential use of preformed physical factors in prodigiozan treatment of chronic salpingo-oophoritis].
    Strugatskiĭ VM; Rastorgueva VM; Tsoĭ S; Kudrina EA
    Vopr Kurortol Fizioter Lech Fiz Kult; 1987; (2):66-8. PubMed ID: 3604127
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined therapy of inflammatory diseases of the female genitalia with prodigiozan].
    Anisimov AV; Lanovoĭ ID; Ivanova TI; Marchuk EA; Novikova KS
    Antibiotiki; 1971 Feb; 16(2):175-7. PubMed ID: 4934038
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of prodigiozan in chronic hematogenous osteomyelitis in children].
    Akhtamov MA; Rakhimov AU; Akhmedov IuM
    Khirurgiia (Mosk); 1985 Jul; (7):92-4. PubMed ID: 4046432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Changes in the factors of nonspecific protection of the body during treatment of inflammatory diseases of the maxillofacial area in elderly persons using prodigiozan].
    Zakson ML; Bordonos VG
    Stomatologiia (Mosk); 1987; 66(6):9-11. PubMed ID: 3481503
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of lysozyme and prodigiozan in the treatment of suppurative infections in diabetics].
    Nuzov BG
    Vestn Khir Im I I Grek; 1984 Apr; 132(4):62-5. PubMed ID: 6730182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.